project id: TCGA-SKCM; case submitter id: TCGA-EB-A3XC; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 9.1; age at index: 74; days to birth: -27124; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 27124; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 650.0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 112; days to sample procurement: 0; initial weight: 180.0; portion submitter id: TCGA-EB-A3XC-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 1.0; percent stromal cells: 19.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;